RSS
SIGN IN
AI radiology tools are closest to full autonomy, but the FDA's regulatory framework still assumes human-in-the-loop oversight.
True if FDA grants approval for an AI system to make diagnostic decisions without mandatory physician review.
Story 18: Federal agency betting $62.7M on autonomous AI clinical management without human oversight — signals regulatory appetite for autonomous clinical AI
Story 18: Anthropic involvement brings frontier safety credibility to autonomous clinical deployment
451 days remaining provides substantial runway
Trump deregulatory posture continues to theoretically accelerate FDA approval timelines
Story 18 is a research/pilot project, not an FDA approval — resolution criterion requires FDA approval of fully autonomous diagnostic tool
Prior authorizations (1,600+) all involve human-in-loop or screening functions — criterion gap persists
AMA lobbying against physician oversight removal structurally unchanged
Liability frameworks for fully autonomous diagnostic tools remain absent
Heart failure management project creates liability precedent questions that could slow rather than accelerate FDA approval pathway